Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release May 29 2026

· Issued by Glenmark Pharmaceuticals Limited via NSE India

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, we are enclosing herewith the Press Release and Management Discussion & Analysis of the Company for the Fourth Quarter ended March 31, 2026.

View Attachment